RXI PHARMACEUTICALS CORP NEW's ticker is RXII and the CUSIP is 74979C808. A total of 15 filers reported holding RXI PHARMACEUTICALS CORP NEW in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 168,462 | $325,000 | 0.05% |
| Intellectus Partners, LLC | 10,000 | $19,000 | 0.01% |
| DRW Securities, LLC | 19,000 | $37,000 | 0.00% |
| SG Americas Securities, LLC | 118,387 | $228,000 | 0.00% |
| First Allied Advisory Services, Inc. | 11,019 | $22,000 | 0.00% |
| Virtu Financial LLC | 12,073 | $23,000 | 0.00% |
| Advisor Group, Inc. | 19 | $0 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 67 | $0 | 0.00% |
| MORGAN STANLEY | 5,718 | $11,000 | 0.00% |
| BlackRock Inc. | 1,115 | $2,000 | 0.00% |